Point of Care Diagnostics

1.1 Infectious disease testing
1.1.1 Human immunodeficiency virus
1.1.2 Tuberculosis
1.1.3 Chlamydia trachomatis/Neisseria gonorrhoea
1.1.4 Human papilloma virus
1.1.5 Methicillin-resistant Staphylococcus aureus
1.1.6 Novel coronavirus (COVID-19)
1.1.7 Other infectious diseases
1.2 Cardiorespiratory and cardiovascular disease testing
1.3 Diabetes testing
1.4 Cancer screening
1.4.1 Colorectal cancer
1.4.2 Other cancers
1.5 Hemostasis testing
1.6 Drugs of abuse testing
1.7 Pregnancy and fertility testing
1.8 Other applications
1.9 Bibliography

• Exhibit 1-1: Incidence and prevalence of selected infectious diseases, by region
• Exhibit 1-2: Cardiovascular disease mortality (‘000), by region, 2011-2016
• Exhibit 1-3: Prevalence of diabetes (‘000), by region, 2010-2045
• Exhibit 1-4: Incidence of selected cancer types, by region, 2020 & 2040
• Exhibit 1-5: Proportion of emergency department visits with reports of illicit drug use, US, 2006-2011 and 2020
• Exhibit 1-6: Number of births (in millions), by country/region, 2020-2040

2.1 Technology Insights
2.1.1 Dipsticks
2.1.2 Immunoassays
2.1.3 Lateral flow assays
2.1.4 Microfluidic sensors
2.1.5 Molecular technologies
2.2 Point of care diagnostic products for infectious disease testing
2.3 Point of care diagnostic products for blood gas/electrolyte/metabolite testing
2.4 Point of care diagnostic products for cardiac marker testing
2.5 Point of care diagnostic products for hemostasis testing
2.6 Point of care diagnostic products for cancer screening
2.7 Point of care diagnostic products for pregnancy and fertility testing
2.8 Point of care diagnostic products for drugs of abuse testing
2.9 Point of care diagnostic products for blood glucose testing
2.10 Point of care diagnostic products for other applications
2.11 Bibliography

• Exhibit 2-1: Selected POC diagnostics products for infectious disease testing, 2021
• Exhibit 2-2: Selected POC diagnostic products for blood gas/electrolyte/metabolite testing, 2021. 2-8
• Exhibit 2-3: Selected point of care diagnostic products for cardiac marker testing, 2021
• Exhibit 2-4: Selected point of care diagnostic products for hemostasis testing, 2021
• Exhibit 2-5: Selected point of care diagnostic products for cancer screening, 2021
• Exhibit 2-6: Selected point of care diagnostic products for pregnancy and fertility testing, 2021
• Exhibit 2-7: Selected point of care diagnostic products for drugs of abuse testing, 2021
• Exhibit 2-8: Selected point of care diagnostic products for blood glucose testing, 2021
• Exhibit 2-9: Selected point of care diagnostic products for other applications, 2021

3.1 Regional insights
3.1.1 United States
3.1.2 Five major European markets
3.1.3 Japan
3.1.4 Rest of world
3.2 Point of care diagnostics, market forecast by product segment
3.2.1 Competitive analysis
3.3 Trends in the point of care diagnostics products market
3.4 Laboratory developed tests
3.5 Market drivers and limiters
3.6 Products for blood gas/electrolyte/metabolite testing, market analysis
3.6.1 Competitive analysis
3.7 Point of care diagnostics for cardiac marker testing, market analysis
3.7.1 Competitive analysis
3.8 Point of care diagnostics for hemostasis testing, market analysis
3.8.1 Competitive analysis
3.9 Point of care diagnostics for infectious disease testing, market analysis
3.9.1 Competitive analysis
3.10 Point of care diagnostics for cancer screening, market analysis
3.10.1 Competitive analysis
3.11 Point of care diagnostics for pregnancy and fertility testing, market analysis
3.11.1 Competitive analysis
3.12 Point of care diagnostics for drugs of abuse testing, market forecast
3.12.1 Competitive analysis
3.13 Point of care diagnostics for blood glucose testing, market forecast
3.13.1 Competitive analysis
3.14 Point of care diagnostics for other applications, market forecast
3.14.1 Competitive analysis
3.15 Bibliography

• Exhibit 3-1: Point of care diagnostics products, combined market forecast ($m), by region, 2020-25
• Exhibit 3-2: Point of care diagnostics products, combined market forecast ($m), by segment, 2020-25
• Exhibit 3-3: Point of care diagnostics products, combined market ($m), global share by supplier, 2020
• Exhibit 3-4: Exact Sciences’ home colorectal cancer screening service revenue ($m), 2015-20
• Exhibit 3-5: Point of care diagnostics for blood gas/electrolyte/metabolite testing, market forecast ($m) by region, 2020-25
• Exhibit 3-6: Market for point of care diagnostics products for blood gas/electrolyte/metabolite testing ($m), global share by supplier, 2020
• Exhibit 3-7: Point of care diagnostics products for cardiac marker testing, market forecast ($m), by region, 2020-25
• Exhibit 3-8: Market for point of care diagnostics products for cardiac marker testing, global share by supplier, 2020
• Exhibit 3-9: Point of care diagnostics products for hemostasis testing, market forecast ($m), by region, 2020-25
• Exhibit 3-10: Point of care diagnostics products market for hemostasis testing, global share by supplier, 2020
• Exhibit 3-11: Point of care diagnostics products for infectious disease testing, market forecast ($m), by region, 2020-25
• Exhibit 3-12: Point of care diagnostics products for infectious disease testing, global share by supplier, 2020
• Exhibit 3-13: Point of care diagnostics products for cancer screening, market forecast ($m), by region, 2020-25
• Exhibit 3-14: Point of care diagnostics products for pregnancy and fertility testing, market forecast ($m), by region, 2020-25
• Exhibit 3-15: Point of care diagnostics products for pregnancy and fertility testing, global share by supplier, 2020
• Exhibit 3-16: Point of care diagnostics products for drugs of abuse testing, market forecast ($m), by region, 2020-25
• Exhibit 3-17: Point of care diagnostics products for drugs of abuse testing, global share by supplier, 2020
• Exhibit 3-18: Point of care diagnostics products for blood glucose testing, market forecast ($m), by region, 2020-25
• Exhibit 3-19: Point of care diagnostics products for professional-use blood glucose testing, market forecast ($m), by region, 2020-25
• Exhibit 3-20: Point of care diagnostics products for blood glucose self-testing, market forecast ($m), by region, 2020-25
• Exhibit 3-21: Point of care diagnostics products for blood glucose testing, global share by supplier, 2020
• Exhibit 3-22: Point of care diagnostics products for other applications, market forecast ($m), by product segment, 2020-25
• Exhibit 3-23: Point of care diagnostics products for other applications, market forecast ($m) by region, 2020-25
• Exhibit 3-24: Point of care diagnostics market for other applications, share by supplier, 2020
• Exhibit 3-25: Point of care diagnostics market for hemoglobin and hematocrit testing, share by supplier, 2020
• Exhibit 3-26: Point of care diagnostics market for urinalysis products, share by supplier, 2020
• Exhibit 3-27: Point of care diagnostics market for glycated hemoglobin testing products, share by supplier, 2020
• Exhibit 3-28: Point of care diagnostics market for allergy testing products, share by supplier, 2020